Do you want to read an article? Please log in or register.
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-up
Thrombosis and Stroke
Related content
Heart, Artery and Coronary Diseases
Coronavirus Disease 2019 (COVID-19) Pandemic Implications in Pediatric and Adult Congenital Heart Disease
J Am Heart Assoc.
Alsaied T, Aboulhosn JA, Cotts TB, Daniels CJ, Etheridge SP, Feltes TF, Gurvitz MZ, Lewin MB, Oster ME, Saidi A
doi: 10.1161/JAHA.120.017224.
Thrombosis and Stroke
COVID-19 Associated Thrombosis and Coagulopathy: Review of the Pathophysiology and Implications for Antithrombotic Management
J Am Heart Assoc
Ortega-Paz L, Capodanno D, Montalescot G, Angiolillo DJ
doi: 10.1161/JAHA.120.019650
Cardiovascular Risk and Diseases
Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19)
JAMA Cardiol.
Guo T, Fan Y, Chen M, Wu X, Zhang L, He T, Wang H, Wan J, Wang X, Lu Z
doi: 10.1001/jamacardio.2020.1017.
Thrombosis and Stroke
Prevention and Treatment of Venous Thromboembolism Associated with Coronavirus Disease 2019 Infection: A Consensus Statement before Guidelines
Thromb Haemost.
Zhai Z, Li C, Chen Y, Gerotziafas G, Zhang Z, Wan J, Liu P, Elalamy I, Wang C, Prevention Treatment of VTE Associated with COVID-19 Infection Consensus Statement Group, Pulmonary Embolism Pulmonary Vascular Diseases Group of the Chinese Thoracic Society, Pulmonary Embolism Pulmonary Vascular Disease Working Committee of Chinese Association of Chest Physicians, National Cooperation Group on Prevention Treatment of Pulmonary Embolism Pulmonary Vascular Disease, National Program Office for Prevention Treatment of Pulmonary Embolism Deep Vein Thrombosis, China Grade Center, Evidence-based Medicine Center of School of Basic Medical Sciences of Lanzhou University.
doi: 10.1055/s-0040-1710019.
Cardiac Arrest or Death
Urgent Guidance for Navigating and Circumventing the QTc-Prolonging and Torsadogenic Potential of Possible Pharmacotherapies for Coronavirus Disease 19 (COVID-19)
Mayo Clin Proc.
Giudicessi JR, Noseworthy PA, Friedman PA, Ackerman MJ
doi: 10.1016/j.mayocp.
Therapy and Intervention
Viral Infections, Non-HIV
Effect of Antithrombotic Therapy on Clinical Outcomes in Outpatients With Clinically Stable Symptomatic COVID-19: The ACTIV-4B Randomized Clinical Trial
JAMA
Connors JM, Brooks MM, Sciurba FC, Krishnan JA, Bledsoe JR, Kindzelski A, Baucom AL, Kirwan BA, Eng H, Martin D, Zaharris E, Everett B, Castro L, Shapiro NL, Lin JY, Hou PC, Pepine CJ, Handberg E, Haight DO, Wilson JW, Majercik S, Fu Z, Zhong Y, Venugopal V, Beach S, Wisniewski S, Ridker PM, ACTIV-4B Investigators.
doi: 10.1001/jama.2021.17272
RECOMMENDED
Cardiovascular Risk and Diseases
Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19
★ 3
Recommended by
Prof. Dr Isabella Sudano, Faculty Member
doi: 10.1056/NEJMoa2007621.
Thrombosis and Stroke
Fibrinolysis Shutdown Correlates to Thromboembolic Events in Severe COVID-19 Infection
J Am Coll Surg.
Wright FL, Vogler TO, Moore EE, Moore HB, Wohlauer MV, Urban S, Nydam TL, Moore PK, McIntyre RC Jr
doi: 10.1016/j.jamcollsurg.2020.05.007.
Cardiovascular Risk and Diseases
Association of Kidney Disease With Outcomes in COVID-19: Results From the American Heart Association COVID-19 Cardiovascular Disease Registry
J Am Heart Assoc
Rao A, Ranka S, Ayers C, Hendren N, Rosenblatt A, Alger HM, Rutan C, Omar W, Khera R, Gupta K, Mody P, DeFilippi C, Das SR, Hedayati SS, de Lemos JA
doi: 10.1161/JAHA.121.020910